IDEX Analyst Price Targets - Benzinga

IDEX Corp

IEXNYSE

Trade with Public

Trade with Public

$238.54

5.332.29%

마지막 업데이트: Oct 28, 4:39 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

IDEX Analyst Price Targets

Wall Street analyst price targets and consensus rating for IDEX (IEX).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

8Buy

2Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$262Upside to Avg. PT+9.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 21, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$270→$275
Oct 14, 2026	RBC Capital	Jeffrey Reive	PT Raise	Outperform	$280→$285
Sep 9, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$265→$270
Aug 12, 2026	Mizuho	Brett Linzey	Upgrade	Neutral→Outperform	$210→$280
Aug 6, 2026	DA Davidson	Matt Summerville	PT Raise	Neutral	$230→$240
Aug 6, 2026	Argus Research	John Eade	PT Raise	Buy	$250→$260
Jul 30, 2026	Citigroup	Vladimir Bystricky	PT Raise	Buy	$252→$269
Jul 30, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$261→$280
Jul 30, 2026	Stifel	Nathan Jones	PT Raise	Buy	$257→$268
Jul 30, 2026	TD Cowen	Joe Giordano	PT Raise	Buy	$260→$275
Jul 21, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$250→$260
Jul 20, 2026	Stifel	Nathan Jones	PT Raise	Buy	$250→$257
Jul 16, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$252→$261
Jun 2, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$242→$250
Apr 30, 2026	Citigroup	Vladimir Bystricky	PT Raise	Buy	$243→$252
Apr 30, 2026	TD Cowen	Joseph Giordano	PT Raise	Buy	$250→$260
Apr 30, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$225→$252
Apr 14, 2026	Stifel	Nathan Jones	PT Cut	Buy	$244→$241
Mar 27, 2026	BMO Capital	Daniel DiCicco	Initiate	Market Perform	$214
Feb 6, 2026	Argus Research	John Eade	Upgrade	Hold→Buy	$240

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $275

Oppenheimer analyst Bryan Blair maintains IDEX (NYSE:IEX) with a Outperform and raises the price target from $270 to $275.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on IDEX, Raises Price Target to $285

RBC Capital analyst Jeffrey Reive maintains IDEX (NYSE:IEX) with a Outperform and raises the price target from $280 to $285.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $270

Oppenheimer analyst Bryan Blair maintains IDEX (NYSE:IEX) with a Outperform and raises the price target from $265 to $270.

Benzinga Newsdesk

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Top analysts upgraded IDEX and Entegris, raised price targets. Intuitive Surgical upgraded with $500 target.

Avi Kapoor

CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio, while B of A cuts Lumentum's target.

Avi Kapoor

PRO
Mizuho Upgrades IDEX to Outperform, Raises Price Target to $280

Mizuho analyst Brett Linzey upgrades IDEX (NYSE:IEX) from Neutral to Outperform and raises the price target from $210 to $280.

Benzinga Newsdesk